Boyds expands regulatory affairs team with senior hire
Katherine Bowen joins global drug development consultancy Boyds as Senior Director of Regulatory Affairs in response to a rise in demand for its specialist regulatory services.
Bowen has over 14 years’ experience in regulatory affairs across both mid to large pharma and consultancies.
“We continue to see an increased demand from biotechs and academic groups looking for our regulatory expertise and support, particularly in advanced therapy medicinal products (ATMPs), and cell and gene therapies,” said Dr Julie Warner, Vice President of Regulatory Affairs at Boyds.
“Katherine’s experience and proven track record of providing strategic regulatory advice across a range of therapeutic areas will be invaluable as we continue to build on this growth and add real value to clients looking to bring their medicines to the market.”
